Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24242786)
Watch
English
Nicotine receptor partial agonists for smoking cessation
scientific article (publication date: 16 July 2008)
In more languages
edit
Statements
instance of
scholarly article
0 references
meta-analysis
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Nicotine receptor partial agonists for smoking cessation
(English)
0 references
main subject
smoking
1 reference
based on heuristic
inferred from title
nicotine
0 references
author name string
Kate Cahill
series ordinal
1
0 references
Lindsay F Stead
series ordinal
2
0 references
Tim Lancaster
series ordinal
3
0 references
publication date
16 July 2008
0 references
published in
Cochrane Database of Systematic Reviews
0 references
cites work
Nicotine addiction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
21 January 2018
Measures of abstinence in clinical trials: issues and recommendations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
21 January 2018
Cytisine for smoking cessation: a literature review and a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Scope and impact of financial conflicts of interest in biomedical research: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
FDA warns of adverse events linked to smoking cessation drug and antiepileptics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antidepressants for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine replacement therapy for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Telephone counselling for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nicotine receptor partial agonists for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of varenicline for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytisine for smoking cessation: a research agenda
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of knock-out mice to determine the molecular basis for the actions of nicotine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome criteria in smoking cessation trials: proposal for a common standard.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measuring inconsistency in meta-analyses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An uncontrolled trial of cytisine (Tabex) for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: new treatment with efficacy in smoking cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuropharmacology and potential efficacy of new treatments for tobacco dependence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: progress in smoking cessation treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Advances in pharmacotherapy for tobacco dependence.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Varenicline: a review of its use as an aid to smoking cessation therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD006103.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/14651858.CD006103.PUB3
0 references
PubMed ID
18646137
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit